Evidence map›Paper›PMID 38305152›Full record

ArticleJournal of virology2024

Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.

Sheng Niu, Zhennan Zhao, Zhimin Liu, Xiaoyu Rong, Yan Chai, Bin Bai, Pengcheng Han, Guijun Shang, Jianle Ren, Ying Wang and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Sheng Niu *College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.ORCID 0000-0002-7090-9346
Zhennan Zhao *CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Zhimin Liu *College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.
Xiaoyu Rong *School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.
Yan ChaiCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Bin BaiCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Pengcheng HanSchool of Medicine, Zhongda Hospital, Southeast University, Nanjing, China.
Guijun ShangCryo-EM Center, Shanxi Academy of Advanced Research and Innovation, Taiyuan, China.
Jianle RenCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.
Ying WangCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.
Xin ZhaoCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Kefang LiuCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Wen-Xia TianCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.ORCID 0000-0001-6018-5180
Qihui WangCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.ORCID 0000-0003-3768-0401
George Fu GaoCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.ORCID 0000-0002-3869-615X
Shanxi Agricultural University · CNChinese Academy of Sciences · CNShanxi Academy of Building Research · CNWenzhou Medical University · CNZhongda Hospital Southeast University · CN

Funding

Distinguished and Excellent Young Scholar Cultivation Project of Shanxi Agricultural University 2022YQPYGC01Excellent Doctoral Award of Shanxi Province for Scientific Research Project SXBYKY2022031MOST | National Natural Science Foundation of China (NSFC) 32202892| Natural Science Foundation of Shanxi Province (Shanxi Natural Science Foundation) 202103021224160Shanxi Key Laboratory of Protein Structure Determination 202104010910006Special Research Fund of Shanxi Agricultural University for High-level Talents 2022XG20The fund for Shanxi "1331 Project" 20211331-13The special fund for Science and Technology Innovation Team of Shanxi Province 202204051001022
6 · The paper itself

Abstract

Pet golden hamsters were first identified being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant of concern (VOC) and transmitted the virus back to humans in Hong Kong in January 2022. Here, we studied the binding of two hamster (golden hamster and Chinese hamster) angiotensin-converting enzyme 2 (ACE2) proteins to the spike protein receptor-binding domains (RBDs) of SARS-CoV-2 prototype and eight variants, including alpha, beta, gamma, delta, and four omicron sub-variants (BA.1, BA.2, BA.3, and BA.4/BA.5). We found that the two hamster ACE2s present slightly lower affinity for the RBDs of all nine SARS-CoV-2 viruses tested than human ACE2 (hACE2). Furthermore, the similar infectivity to host cells expressing hamster ACE2s and hACE2 was confirmed with the nine pseudotyped SARS-CoV-2 viruses. Additionally, we determined two cryo-electron microscopy (EM) complex structures of golden hamster ACE2 (ghACE2)/delta RBD and ghACE2/omicron BA.3 RBD. The residues Q34 and N82, which exist in many rodent ACE2s, are responsible for the lower binding affinity of ghACE2 compared to hACE2. These findings suggest that all SARS-CoV-2 VOCs may infect hamsters, highlighting the necessity of further surveillance of SARS-CoV-2 in these animals.IMPORTANCESARS-CoV-2 can infect many domestic animals, including hamsters. There is an urgent need to understand the binding mechanism of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants to hamster receptors. Herein, we showed that two hamster angiotensin-converting enzyme 2s (ACE2s) (golden hamster ACE2 and Chinese hamster ACE2) can bind to the spike protein receptor-binding domains (RBDs) of SARS-CoV-2 prototype and eight variants and that pseudotyped SARS-CoV-2 viruses can infect hamster ACE2-expressing cells. The binding pattern of golden hamster ACE2 to SARS-CoV-2 RBDs is similar to that of Chinese hamster ACE2. The two hamster ACE2s present slightly lower affinity for the RBDs of all nine SARS-CoV-2 viruses tested than human ACE2. We solved the cryo-electron microscopy (EM) structures of golden hamster ACE2 in complex with delta RBD and omicron BA.3 RBD and found that residues Q34 and N82 are responsible for the lower binding affinity of ghACE2 compared to hACE2. Our work provides valuable information for understanding the cross-species transmission mechanism of SARS-CoV-2.

Indexed as

Angiotensin-Converting Enzyme 2CricetulusCryoelectron MicroscopyHost SpecificityMesocricetusAnimalsCell LineCOVID-19CricetinaeHumansMutationPetsProtein BindingSARS-CoV-2Spike Glycoprotein, CoronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2binding affinitycryo-EM structurehamsterRBDSARS-CoV-2

Identifiers

PMID38305152
PMCPMC10949455
OpenAlexW4391485615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.